Active Sep 22Toronto

Cross-Border Impact Ventures

Cross-Border Impact Ventures is a Toronto-based specialist investor in healthtech and life sciences, can lead rounds, and backs companies like Sonio and Daye.

Entry stagen/a
Check sizen/a
Leads roundsYes
FocusHealthtech, Life sciences
Latest fund$58M (2026)$58M (Fund II, first close) (2026)
Investing team5 people1 activity update, latest Sep 22

Who you would pitch at Cross-Border Impact Ventures

5 people on the investing team, 4 of them partners who can make the call. Partners are listed first.

Work here and something is wrong? Ask for a correction.

Check size not reported yet.

Bars: how many firms in the atlas report each band. Highlighted: this firm.

1 activity update since September, latest Sep 22.

Weekly count of activity updates. Activity is not a confirmed deal.

Notable investments

SonioDayeCardiosense
Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Alert me when Cross-Border Impact Ventures is active

One email when this firm shows new activity. Nothing else.

Questions

What stage does Cross-Border Impact Ventures invest in?

Cross-Border Impact Ventures has not reported an entry stage.

How much does Cross-Border Impact Ventures invest?

Cross-Border Impact Ventures has not reported a check size.

Does Cross-Border Impact Ventures lead rounds?

Yes. Cross-Border Impact Ventures says it can lead.

Who are the partners at Cross-Border Impact Ventures?

Annie Theriault (Managing Partner), Donna Parr (Managing Partner), Femke Smeets (Managing Director of Emerging Markets), Megan Dover (Partner).

Is Cross-Border Impact Ventures active right now?

Cross-Border Impact Ventures has shown 1 activity update since September 2026, the latest on 2026-09-22.

Work at Cross-Border Impact Ventures? Claim or correct this profile.